Skip to main content
. 2018 Feb 15;15(4):5767–5771. doi: 10.3892/ol.2018.8063

Figure 2.

Figure 2.

Serum miR-200a expression levels in patients with glioma before chemotherapy and healthy subjects in the control group. The serum level of miR-200a in patients with glioma before chemotherapy was significantly lower than that in healthy subjects. ***P<0.001.